Congestion pricing turned six months old Saturday, and Gov. Kathy Hochul is boasting that the tolling program is reducing traffic in the city, among other benefits. The number of vehicles is down 11%, ...

The European Commission has renewed its data adequacy agreement with the UK, guaranteeing free flow of data with the European Union (EU) for a further six years. The agreement assures that the UK’s ...

Cardiovascular disease remains the leading global killer. Still, too many late-stage cardiology trials stumble, not for lack of biology, but because episodic, clinic-bound measures miss what matters ...

The last decade-plus has seen a wealth of advancements designed to secure data at the microprocessor level, but a team of academic researchers recently punched through those defenses with a tiny ...

Detection and response are crucial for protecting corporate networks from attacks. What do NDR, EDR and XDR stand for and what distinguishes one from the other? The constantly growing number of ...

The enhanced UltraFICO score solution uses Plaid's systems to accept and analyze real-time cash-flow data, or information about the money moving in and out of a consumer's financial accounts. Older ...

For consumers who are heavy on savings and light on credit history, a new partnership in the world of credit scores could help them lock down a loan. FICO, the company basically synonymous with the ...

WASHINGTON, Nov 18 (Reuters) - A divided U.S. Federal Reserve begins receiving updated economic reports from the now-reopened federal government this week as policymakers hope for clarity in their ...

Researchers at UC San Diego and the University of Maryland have discovered that huge amounts of satellite communications — including calls, texts, and internet data from civilian, commercial, ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

GSK and Spero Therapeutics have shared phase 3 results on their antibiotic candidate, revealing that the oral therapy closely matched the intravenous incumbent in a trial that could support filings ...